{"filings":[{"id":184824,"accession_number":"0001493152-25-010288","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Resonate Blends CEO James Morrison resigns; James W. Zimbler appointed as President/CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Morrison resigned as President/CEO effective March 5, 2025, but remains on the Board.","James W. Zimbler appointed President/CEO and Director, effective March 5, 2025.","Zimbler previously served as Director and VP of Corporate Finance since March 2024.","Zimbler tasked with reorganizing the company, negotiating with creditors, and pursuing potential M&A.","Morrison's resignation letter states no dispute or disagreement regarding operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217425,"accession_number":"0001493152-24-031326","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["1.01","5.02","5.07","9.01"],"status":"ready","headline":"Resonate Blends restructures share exchange to asset deal, adds directors, approves name change","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Reformation Agreement converts prior share-for-share Exchange to share-for-asset structure, rescinding prior issuances and assignments.","Company re-issued shares to EMGE in exchange for capital stock of Evolutionary Biologics, Apollo Biowellness, Nanosthetic, and Nanogistics.","Sandy Lipkins resigned from board July 29; no disagreement; Jay Lucas and Bobby Carpenter appointed as directors.","Majority shareholder approved corporate name change to 'Apollo Biowellness, Inc.' pending FINRA approval.","Company intends to file Form S-1 to distribute shares to EMGE shareholders at a future date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237276,"accession_number":"0001493152-24-014759","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K/A","filed_at":"2024-04-16T23:59:59+00:00","items":["1.01","2.01","5.01","5.02","9.01"],"status":"ready","headline":"Resonate Blends closes EMGE share exchange, gains control of EMGE business; transfers subsidiaries to ex-director","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed Exchange Agreement: EMGE preferred shareholders exchanged equity for Series F Preferred Stock convertible into 93% of fully diluted common stock.","Conveyance Agreement: Company transferred ownership of Resonate Blends, LLC and Entourage Labs, LLC to former director Selzer, who assumed all liabilities.","All prior directors and officers resigned; four new board members appointed.","Company's ongoing business is now that of EMGE, a regenerative medicine company with subsidiaries including Evolutionary Biologics, Juventix, and others.","Series F Preferred Stock carries $1,800 liquidation preference per share, no voting rights, convertible after six months or upon uplisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254825,"accession_number":"0001493152-24-010614","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2024-03-20T23:59:59+00:00","items":["1.01","2.01","5.01","5.02","9.01"],"status":"ready","headline":"Resonate Blends closes share exchange with EMGE, new board and control shift","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["EMGE Preferred shareholders exchanged equity for Series F Convertible Preferred convertible to 93% of common on fully diluted basis.","Control change: Geoffrey Selzer sold 2M Series C Preferred shares to James Morrison for $10, granting Morrison voting control.","Company conveyed subsidiaries Resonate Blends LLC and Entourage Labs LLC to former director Selzer, who assumed all liabilities.","Prior directors resigned; new appointees: James Morrison (Pres., Sec., Dir.), Lance Liberti, Sandy Lipkins, James Zimbler.","Series F Preferred: $1,800 liquidation preference per share, no dividends/voting, convertible after 6 months or upon uplist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254824,"accession_number":"0001493152-24-009249","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Resonate Blends amends EMGE deal minimum to $250K; issues 9.6M anti-dilution shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment reduces minimum investment from $500K to $250K before closing of Emergent Health Corp. exchange.","Issued 9,555,435 common shares as anti-dilution protection under Membership Interest Purchase Agreements.","Shares issued to officers and directors, including CEO Geoffrey Selzer and David Thielen.","Issuance was exempt under Section 4(a)(2) and Rule 506(b) of the Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254823,"accession_number":"0001493152-24-007792","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Resonate Blends enters share exchange giving EMGE holders 93% of pro forma common stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Preferred shareholders of Emergent Health will exchange equity for new preferred shares convertible into 93% of common stock on a fully diluted basis.","Current Resonate Blends shareholders will own approximately 7% of fully diluted capitalization post-exchange.","Closing expected by March 1, 2024; conditions include sale of two subsidiaries to CEO Geoffrey Selzer and raising $500,000.","Post-closing: new board led by Jim Morrison (Chairman/CEO), redomicile to Delaware, and name change to Apollo Health and Wellness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272298,"accession_number":"0001493152-23-044760","cik":897078,"company_name":"Resonate Blends, Inc.","ticker":"KOAN","form_type":"8-K","filed_at":"2023-12-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Pegasus terminates merger with Resonate Blends over capital failure","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pegasus Specialty Vehicles terminated the June 20, 2023 Merger Agreement on December 7, 2023.","Termination cites Resonate's failure to secure the committed $3,000,000 investment for Pegasus.","Resonate also failed to provide capital to repay a $500,000 note with 622 Capital, LLC.","Resonate disagrees with the termination grounds and is in active negotiations to resolve.","The merger would have made Pegasus a wholly-owned subsidiary of Resonate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":195249.09090909088,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}